Cell- rather than antibody-mediated immunity leads to the development of profound thrombocytopenia during experimental Plasmodium berghei malaria

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7699-7707

  Gramaglia, Irene ^a   Sahlin, Herman ^a   Nolan, John P ^a   Frangos, John A ^a   Intaglietta, Marcos ^a   Van Der Heyde, Henri C ^a  

^a LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 12; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL DESTRUCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMORAL IMMUNITY; MALARIA; MOUSE; NONHUMAN; PATHOGENESIS; PLASMODIUM BERGHEI; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SURVIVAL; THROMBOCYTE; THROMBOCYTOPENIA;

EID: 28244489598     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7699     Document Type: Article

References (52)

1. Levi, M., T. T. Keller, E. van Gorp, and H. Ten Cate. 2003. Infection and inflammation and the coagulation system. Cardiovasc. Res. 60: 26-39.
2. Cines, D. B., and V. S. Blanchette. 2002. Immune thrombocytopenic purpura. N. Engl. J. Med. 346: 995-1008.
3. Kunicki, T. J., K. Furihata, and D. Nugent. 1988. Glycoprotein IIb-IIIa as an immunologic target. Curr. Stud. Hematol. Blood Transfus. 44-63.
4. Kunicki, T. J., and P. J. Newman. 1992. The molecular immunology of human platelet proteins. Blood 80: 1386-1404.
5. He, R., D. M. Reid, C. E. Jones, and N. R. Shulman. 1994. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood 83: 1024-1032.
6. Semple, J. W. 2002. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev. 16: 9-12.
7. Marsh, K., M. English, J. Crawley, and N. Peshu. 1996. The pathogenesis of severe malaria in African children. Ann. Trop. Med. Parasitol. 90: 395-402.
8. Marsh, K., D. Forster, C. Warairu, I. Mwangi, M. Winstanley, V. Marsh. C. Newton, P. Winstanley, P. Warn, and N. Peshu. 1995. Indicators of life-threatening malaria in African children. N. Engl. J. Med. 332: 1399-1404.
9. Krogstad, D. J. 1999. Malaria. In Tropical Infectious Diseases: Principles, Pathogens, and Practice. R. L. Guerrant, D. H. Walker, and P. F. Weller, eds. Churchill Livingstone, Philadelphia, pp. 736.
10. Punyagupta, S., T. Srichaikul, P. Nitiyanant, and B. Petchclai. 1974. Acute pulmonary insufficiency in falciparum malaria: summary of 12 cases with evidence of disseminated intravascular coagulation. Am. J. Trop. Med. Hyg. 23: 551-559.
11. Srichaikul, T., P. Puwasatien, J. Karnjanajetanee, V. A. Bokisch, and P. Pawasatien. 1975. Complement changes and disseminated intravascular coagulation in Plasmodium falciparum malaria. Lancet 1: 770-772.
12. Horstmann, R. D., and M. Dietrich. 1985. Haemostatic alterations in malaria correlate to parasitaemia. Blut 51: 329-335. .
13. Mohanty, D., N. Marwaha, K. Ghosh, A. P. Chauhan, S. Shah, S. Sharma, and K. C. Das. 1985. Vascular occlusion and disseminated intravascular coagulation in falciparum malaria. Br. Med. J. 290: 115-116.
14. Kelton, J. G., J. Keystone, J. Moore, G. Denomme, E. Tozman, M. Glynn, P. B. Neame, J. Gauldie, and J. Jensen. 1983. Immune-mediated thrombocytopenia of malaria. J. Clin. Invest. 71: 832-836.
15. Seka-Seka, J., Y. Brouh, A. C. Yapo-Crezoit, and N. H. Atseye. 2004. The role of serum immunoglobulin E in the pathogenesis of Plasmodium falciparum malaria in Ivorian children. Scand. J. Immunol. 59: 228-230.
16. Grau, G. E., P. F. Piguet, D. Gretener, C. Vesin, and P. H. Lambert. 1988. Immunopathology of thrombocytopenia in experimental malaria. Immunology 65: 501-506.
17. Sørensen, P. G., H. Mickley, and K. G. Schmidt. 1984. Malaria-induced immune thrombocytopenia. Vox Sang. 47: 68-72.
18. Hearn, J., N. Rayment, D. N. Landon, D. R. Katz, and J. B. de Souza. 2000. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect. Immun. 68: 5364-5376.
19. Mackey, L. J., A. Hochmann, C. H. June, C. E. Contreras, and P. H. Lambert. 1980. Immunopathological aspects of Plasmodium berghei infection in five strains of mice. II. Immunopathology of cerebral and other tissue lesions during the infection. Clin. Exp. Immunol. 42: 412-420.
20. Rest, J. R. 1982. Cerebral malaria in inbred mice. 1. A new model and its pathology. Trans. R. Soc. Trop. Med. Hyg. 76: 410-415.
21. Männel, D. N., and G. E. Grau. 1997. Role of platelet adhesion in homeostasis and immunopathology. Mol. Pathol. 50: 175-185.
22. Grau, G. E., F. Tacchini-Cottier, C. Vesin, G. Milon, J. N. Lou, P. F. Piguet, and P. Juillard. 1993. TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction. Eur. Cytokine Network 4: 415-419.
23. Sun, G., W.-L. Chang, J. Li, S. M. Berney, D. Kimpel, and H. C. van der Heyde. 2003. Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria. Infect. Immun. 71: 6553-6561.
24. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350: 423-426.
25. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
26. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
27. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26: 1553-1559.
28. Smyth, S. S., E. D. Reis, H. Vaananen, W. Zhang, and B. S. Coller. 2001. Variable protection of β3-integrin-deficient mice from thrombosis initiated by different mechanisms. Blood 98: 1055-1062.
29. Chang, W. L., H. C. van der Heyde, and B. S. Klein. 1998. Flow cytometric quantitation of yeast a novel technique for use in animal model work and in vitro immunologic assays. J. Immunol. Methods 211: 51-63.
30. - γδ T cell subset in the spleens of mice during blood-stage malaria. J. Immunol. 151: 6311-6317.
31. + T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect. Immun. 69: 7341-7348.
32. Yañez, D. M., D. D. Manning, A. J. Cooley, W. P. Weidanz, and H. C. van der Heyde. 1996. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157: 1620-1624.
33. Combes, V., N. Coltel, M. Alibert, M. van Eck, C. Raymond, I. Juhan-Vague, G. E. Grau, and G. Chimini. 2005. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am. J Pathol. 166: 295-302.
34. Musaji, A., F. Cormont, G. Thirion, C. L. Cambiaso, and J. P. Coutelier. 2004. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses. Blood 104: 2102-2106.
35. van der Heyde, H. C., I. Gramaglia, G. Sun, and C. Woods. 2005. Platelet depletion by anti-CD41 (αIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines. Blood 105: 1956-1963.
36. Lucas, R., P. Juillard, E. Decoster, M. Redard, D. Burger, Y. Donati, C. Giroud, C. Monso-Hinard, T. De Kesel, W. A. Buurman, et al. 1997. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27: 1719-1725.
37. Kossodo, S., C. Monso, P. Juillard, T. Velu, M. Goldman, and G. E. Grau. 1997. Interleukin-10 modulates susceptibility in experimental cerebral malaria. Immunology 91: 536-540.
38. Jennings, V. M., A. A. Lal, and R. L. Hunter. 1998. Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria. Infect. Immun. 66: 5972-5979.
39. Favre, N., C. Da Laperousaz, B. Ryffel, N. A. Weiss, B. A. Imhof, W. Rudin, R. Lucas, and P. F. Piguet. 1999. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect. 1: 961-968.
40. Combes, V., A. R. Rosenkranz, M. Redard, G. Pizzolato, H. Lepidi, D. Vestweber, T. N. Mayadas, and G. E. Grau. 2004. Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment. Am. J. Pathol. 164: 781-786.
41. Chang, W. L., J. Li, G. Sun, H. L. Chen, R. D. Specian, S. M. Berney, D. N. Granger, and H. C. van der Heyde. 2003. P-selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature. Infect. Immun. 71: 1911-1918.
42. Li, J., W. L. Chang, G. Sun, H. L. Chen, R. D. Specian, S. M. Berney, D. Kimpel, D. N. Granger, and H. C. van der Heyde. 2003. Intercellular adhesion molecule 1 is important for the development of severe, experimental malaria but is not required for leukocyte adhesion in the brain. J. Investig. Med. 51: 128-140.
43. Bauer, P. R., H. C. van der Heyde, G. Sun, R. D. Specian, and D. N. Granger. 2002. Regulation of endothelial cell adhesion molecule expression in an experimental model of cerebral malaria. Microcirculation 9: 463-470.
44. Piguet, P. F., C. D. Kan, C. Vesin, A. Rochat, Y. Donati, and C. Barazzone. 2001. Role of CD40-CVD40L in mouse severe malaria. Am. J. Pathol. 159: 733-742.
45. Piguet, P. F., C. D. Kan, and C. Vesin. 2002. Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab. Invest. 82: 1155-1166.
46. Piguet, P. F., C. D. Kan, and C. Vesin. 2002. Thrombocytopenia in an animal model of malaria is associated with an increased caspase-mediated death of thrombocytes. Apoptosis 1: 91-98.
47. van der Heyde, H. C., M. M. Elloso, W. L. Chang, B. J. Pepper, J. Batchelder, and W. P. Weidanz. 1996. Expansion of the γδ T cell subset in vivo during bloodstage malaria in B cell-deficient mice. J. Leukocyte Biol. 60: 221-229.
48. Weidanz, W. P., J. R. Kemp, J. M. Batchelder, F. K. Cigel, M. Sandor, and H. C. van der Heyde. 1999. Plasticity of immune responses suppressing parasitemia during acute Plasmodium chabaudi malaria. J. Immunol. 162: 7383-7388.
49. Piguet, P. F., and C. Vesin. 2002. Modulation of platelet caspases and life-span by anti-platelet antibodies in mice. Eur. J. Haematol. 68: 253-261.
50. Piguet, P. F., C. Vesin, and C. Da Kan. 2002. Activation of platelet caspases by TNF and its consequences for kinetics. Cytokine 18: 222-230.
51. Madrenas, J., L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/ partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185: 219-229.
52. Madrenas, J., R. H. Schwartz, and R. N. Germain. 1996. Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists. Proc. Natl. Acad. Sci. USA 93: 9736-9741.